Amro Stino, MD
Neurology · Ann Arbor, MINPI 1609193408
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,944 of the $24,755 with a category attached, or 76.5%. 5 manufacturers reported payments, led by Argenx US, Inc. at 56.6% of the total. Reporting peaked in 2024 at $21,963 and has fallen 97.7% since, to $500 in 2025.
Across 27 payments — averaging $916.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Argenx US, Inc.$14K
- CSL Behring$10K
- Octapharma USA, Inc.$500
- Mallinckrodt Hospital Products Inc.$125
- Akcea Therapeutics, Inc.$108
Across 2 payments — averaging $607.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$1K
What the payments were for
- Consulting fees$18,94477%
- Speaking & faculty fees$2,45010%
- Travel & lodging$2,54710%
- Food & beverage$8143%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Argenx US, Inc. | 15 | $14,008 |
| CSL Behring | 9 | $10,014 |
| Octapharma USA, Inc. | 1 | $500 |
| Mallinckrodt Hospital Products Inc. | 1 | $125 |
| Akcea Therapeutics, Inc. | 1 | $108 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,755 in reported general payments places this provider in the 85th percentile of 652 neurology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 73 | $1,375,006 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 19 | $396,919 |
| PanzygaImmun Glob G(Igg)-Ifas/Glycine | 12 | $363,610 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 30 | $184,195 |
| Cromolyn Sodium | 19 | $20,555 |
| Nurtec OdtRimegepant Sulfate | 12 | $11,161 |
| Pyridostigmine Bromide | 94 | $8,704 |
| Mycophenolate Mofetil | 34 | $5,208 |
| Droxidopa | 15 | $3,625 |
| Midodrine Hcl | 29 | $3,035 |
| Gabapentin | 131 | $2,884 |
| Clonidine | 13 | $2,137 |
| Metaxalone | 11 | $2,053 |
| Nortriptyline Hcl | 87 | $1,876 |
| Duloxetine Hcl | 58 | $1,405 |
Paid to pharmacies, not to this prescriber.
Other neurology in Ann Arbor
- Wade CooperAnn Arbor$991K
- James WeintraubAnn Arbor$194K
- Maysa HamadeAnn Arbor$90K
- Kelvin ChouAnn Arbor$52K
- Aaron EllenbogenFarmington Hills$1.6M
- Matthew HoltzmanWayne$1.4M
- Richard TroschFarmington Hills$1.2M
- Bisena BulicaDetroit$900K
- Julie BurnhamMount Clemens$836K
- Amit MasihOkemos$785K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.